Zirtek Allergy 10mg tablets Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

zirtek allergy 10mg tablets

de pharmaceuticals - cetirizine hydrochloride - oral tablet - 10mg

Atarax 10 mg film-coat. tabl. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atarax 10 mg film-coat. tabl.

ucb pharma sa-nv - hydroxyzine dihydrochloride 10 mg - film-coated tablet - 10 mg - hydroxyzine hydrochloride 10 mg - hydroxyzine

Atarax 25 mg film-coat. tabl. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atarax 25 mg film-coat. tabl.

ucb pharma sa-nv - hydroxyzine dihydrochloride 25 mg - film-coated tablet - 25 mg - hydroxyzine hydrochloride 25 mg - hydroxyzine

Xyzall 5 mg film-coat. tabl. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xyzall 5 mg film-coat. tabl.

ucb pharma sa-nv - levocetirizine dihydrochloride 5 mg - film-coated tablet - 5 mg - levocetirizine (di)hydrochloride 5 mg - levocetirizine

Xyzall 5 mg/ml oral drops sol. dropper cont. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xyzall 5 mg/ml oral drops sol. dropper cont.

ucb pharma sa-nv - levocetirizine dihydrochloride 5 mg/ml - oral drops, solution - 5 mg/ml - levocetirizine (di)hydrochloride 5 mg/ml - levocetirizine

Xyzall 0.5 mg/ml or. sol. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xyzall 0.5 mg/ml or. sol.

ucb pharma sa-nv - levocetirizine dihydrochloride 0,5 mg/ml - oral solution - 0,5 mg/ml - levocetirizine (di)hydrochloride 0.5 mg/ml - levocetirizine

Zyrtec 10 mg/ml oral drops sol. dropper cont. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zyrtec 10 mg/ml oral drops sol. dropper cont.

ucb pharma sa-nv - cetirizine dihydrochloride 10 mg/ml - oral drops, solution - 10 mg/ml - cetirizine dihydrochloride 10 mg/ml - cetirizine

Zyrtec 1 mg/ml or. sol. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zyrtec 1 mg/ml or. sol.

ucb pharma sa-nv - cetirizine dihydrochloride 1 mg/ml - oral solution - 1 mg/ml - cetirizine dihydrochloride 1 mg/ml - cetirizine

Min-I-Jet Atropine Sulphate 1mg/10mL injection syringe vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

min-i-jet atropine sulphate 1mg/10ml injection syringe vial

bppr consulting - atropine sulfate monohydrate -

KEPPRA levetiracetam 1000mg tablet Australien - engelska - Department of Health (Therapeutic Goods Administration)

keppra levetiracetam 1000mg tablet

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: macrogol 6000; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.